FDA Investigator William C Lubas
William C Lubas has conducted inspections on 66 sites in 1 countries as of 19 Aug 2003. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
66
Last Inspection Date:
19 Aug 2003
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with William C Lubas:
Alia Legaux,
Amy Kim,
Anthony N Onianwa,
Brian J Ryan,
Cara M Minelli,
Carolyn J Cook,
Catherine M Beer,
Daniel L Aisen,
David A Carlson,
David A Trent Carlson,
Denise L Terzian,
Elizabeth H Davis,
Erin L Nagel,
Evelyn Taha,
George C Amedro,
Harry J Brewer,
Hoimay Chan,
Irina Gaberman,
James D Bridges,
Jeanette L Mcginnis,
Joan A Loreng,
Joel R Merriman,
Juan Rjimenez Garcia,
Karan L Blum,
Karen L Kosar,
Kathryn A Nagy,
Kim M Downing,
Kimberley A Ricketts,
Kip J Hanks,
Lauren E Blaser,
Linda M Sacco,
LTJG Matthew R Palo,
Marc S Neubauer,
Marlene L Davis,
Mary T Carden,
Matthew D Schnittker,
Michael A Charles,
Michael P Sweeney,
Michael W Burd,
Nancy L Neiger,
Nicholas C Mendiola,
Patricia A Clark,
Paul E Stein,
Richard K Glabach,
Robert J Veitch,
Russ E Davis,
Sarah Forney,
Tammy S Notto,
Wendy M Stone,
William J Leonard
William C Lubas's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2000 | FDA 483 | The American Red Cross dba Union Road Blood Donation Center - Form 483, 2000-06-08 |
August, 2000 | FDA 483 | Chomplain Valley Physicians Hosp Med. Center - Form 483, 2000-08-25 |
July, 2003 | FDA 483 | DJ Acquisition FTT LLC, DBA Weco Manufacturing Group - Hennrietta - Form 483, 2003-07-15 |
April, 2000 | FDA 483 | American National Red Cross (the) - Form 483, 2000-04-10 |
November, 2000 | FDA 483 | Rochester General Hospital - Form 483, 2000-11-15 |
August, 2000 | FDA 483 Response | University of Vermont Health Network CVPH - Form 483R, 2000-09-07 |
May, 2002 | EIR | Finger Lk's Donor Recov. Netw'k- U of R Organ Procur. Prgm. - EIR, 2002-05-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more